•  
  •  
 

OSR Journal of Student Research

Article Title

Effects of low dose methamphetamine in a Drosophila melanogaster model of traumatic brain injury (TBI)

Abstract

According to the Centers for Disease Control and Prevention, traumatic brain injury (TBI) contributes to about 30% of all injury-related deaths in the United States. A TBI is caused by a bump or blow to the head that interrupts the normal functioning of the brain. Previous studies have demonstrated methamphetamine efficacy in a rat model with severe TBI. The present 47 5th Annual Student Research Symposium Meeting of the Minds Event Program study examined the effects of methamphetamine in a Drosophila melanogaster model of TBI. The two Drosophila strains that were used in this study are 00C (n = 1300; male) and Aβ-42 (n = 1300; male.) Aβ-42 flies express a mutant peptide that results in an Alzheimer’s phenotype. 00C serves as the control strain. Aβ-42 flies were utilized because it has been shown that Alzheimer’s may occur as a long-term result of TBI. TBI was induced in 0-1 days old flies using the high intensity trauma (HIT) device. The treatment groups receive methamphetamine (0.06% per day) in a fixed-dose schedule across 25 treatment days. The Lifespan and health-span assays were performed both before and during the treatment. One-way ANOVA results showed that there wasn’t a significant effect of methamphetamine on 00C and Aβ42 flies with/without TBI for the condition (p > 0.05.) In contrast with previous research, our study found that methamphetamine was not effective in improving the TBI condition amongst Drosophila. A likely explanation is that a lower dosage of methamphetamine was used. In conclusion methamphetamine, at the state dosage doesn’t seem to benefit Drosophila with TBI in either strain.

This document is currently not available here.

Share

COinS